Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Key benefits Why people compare it 1 22.5% mean body weight reduction at 15mg in SURMOUNT-1 (N=2,539, 72 weeks) 2 Dual GIP/GLP-1 receptor activation for combined metabolic effects beyond single-agonist therapy 3 63% of participants at highest dose achieved at least 20% weight loss vs 1.3% placebo 4 Superior A1C reduction of 2.07-2.59% with up to 97% of diabetic participants reaching target 5 Outperformed semaglutide 1mg head-to-head in SURPASS-2 for both weight and glycemic endpoints 6 Enhanced adipose tissue lipid handling and fat redistribution via GIPR signaling 7 Significant improvements in triglycerides, blood pressure, and waist circumference across all doses 8 Once-weekly dosing supported by 120-hour half-life and C20 fatty diacid albumin binding Deep research Tirzepatide is a 39-amino-acid synthetic peptide with a molecular weight of 4,813.45 Da
Blood Tests To identify electrolyte abnormalities or nutritional deficiencies
Contact your trial coordinator before travelling
Annals of Nutrition and Metabolism, 81(Suppl
This article will explore why these three specific compounds are often taken together, the science behind their interaction, and why the delivery method matters for your results
The trade-off is 1 to 3 injections per day instead of one, and a slightly higher monthly cost
US$ 23.66
US$ 26.10
US$ 23.51
US$ 22.92
US$ 22.83
